Who?
Customers and teams
#4471Wholesaler, Germany, 4,000 packs#4502Wholesaler, Austria, 2,500 packsOE-QA-OPSQA OperationsQP-02Qualified Person
ERP, QMSwaiting for this batch
Rhenalis Pharma UK Limited · London·,
Getting started with AI · Pharma & Biotech
Rhenalis doesn’t exist. Everything else on this page will feel familiar.
Rhenalis develops and makes its own medicines. This page is set in one plant: in Basel, it makes film-coated tablets, hard capsules, prolonged-release pellets and granules in sachets. No batch leaves the plant without a certificate from the Qualified Person.
demi turns your systems into one record, carries over your rights and lets AI agents prepare the routine work. First the data, then the rights, then the AI. A person always approves.
What five use cases free up
+641 h per yearEstimate, not a promise≈ €41,665 per year, calculated cautiouslyFT-500
Film-coated tablets 500 mg
30 film-coated tablets · For oral use. Read the package leaflet.
PC 09521234005001
SN 7Q3K9X2M4T8W
Lot 26-0409
EXP 10.2029
Rhenalis Pharma AG · 4058 Basel · Switzerland
The problem
There is a new deviation at QA Operations in the Basel plant. Overnight, the breaking force of film-coated tablet FT-500 at tablet press T3 fell below the IPC limit. The shift stopped the press at 3:35 am and put batch 26-0412 on hold.
The questions are always the same: Has this happened before? Did the CAPA from back then work? Which batches ran under the same conditions? Where the answers are:
In the QMSTwo similar cases from 2025. One is called “Hardness too low”, the other “Capping after punch change”.
In the MESWhich batches ran on T3 since the punch change on 2 November, and with which IPC values.
In the DMSWhether the CAPA from 2025 was ever checked for effectiveness.
Until now, QA spends two days searching three systems and old PDF reports. For that long, four batches sit in quarantine and two markets wait for goods.
IPC tableting, press T3eBR 26-0412 · step 7.3 · night shift
| 1:30 | Breaking force Ø 101 N · weight 651 mg |
|---|---|
| 2:00 | Breaking force Ø 97 N · weight 650 mg |
| 2:30 | Breaking force Ø 92 N · weight 652 mg |
| 3:00 | Breaking force Ø 88 N, below 90 N · weight 651 mg |
| 3:30 | Breaking force Ø 86 N, below 90 N · press stopped |
Target: breaking force 90 to 160 N · weight 650 mg ±5%
Together that is 3,744 hours a year, about 2.1 full-time roles, for these five processes alone.
Whether an error has happened before and whether the CAPA worked is in old reports. Recurring deviations are spotted late, sometimes only in the inspection.
For each product, a year of batches, test results, deviations, change controls and stability data: every Product Quality Review starts with collecting.
An authority or a partner wants to see SOPs, training records, qualifications and audit trails, immediately and without gaps.
What demi does · An example
This is how the same Wednesday runs once deviations are live, from week 1.
demi reads AB-26-0731 and the electronic batch record of 26-0412. From 2:30 am, the breaking force falls; weight and compression force stay within target.
In the QMS, demi finds two similar deviations at T3: AB-25-0388 in March and AB-25-0912 in October 2025. Both came a few days after a punch change, and both are worded differently there.
CAPA-25-041 was meant to change the start-up check of new punch sets. It has been closed since January. There is no effectiveness check.
Since the punch change on 2 November, four batches have run on T3: 26-0398, 26-0403, 26-0409 and 26-0412. In 26-0409, the breaking force is close to the limit but within target. It is already packed.
A report on the template from SOP-QA-014: sequence of events, impact assessment with the LIMS values for dissolution and friability, classification “major” as a proposal with reasoning, plus a CAPA draft with an effectiveness check after three batches.
QA classifies the deviation as “major”, sets the CAPA and orders an additional friability test for 26-0412. QA decides on the four batches once the results are in. Only the Qualified Person may certify.
A deviation with a history and four batches does not happen every day. Further down, we calculate with an ordinary deviation and leave the quarantine out: four hours, 25% of that, times 0.6 is 36 minutes freed up per deviation.
2Rights
In a GMP plant, it is set down who may do what: who adds to a batch record, who closes a deviation, who certifies a batch. In demi, that stays exactly the same. The Qualified Person certifies, QA closes deviations, and only those who need the dossier and manufacturing process see them.
The earlier a department handles a batch, the further forward it stands: first Supply Chain with the active substance and excipients, last Regulatory Affairs with the dossier. Underlined in pink: departments that see the dossier and manufacturing process in full.
64 + 96 + 520 + 150 + 182 + 128 + 64 + 36 = 1,240 people at the Basel plant
| Who | Dossier & process | Batches & eBR | Lab & stability | Deviations & CAPA | Suppliers | HR | Approves |
|---|---|---|---|---|---|---|---|
| Qualified Person | reads | reads | reads | reads | reads | – | Certifies the batch |
| QA Operations | reads | checks | reads | edits | reads | – | Closes the deviation |
| Formulation & scale-up | edits | reads | reads | reads | – | – | New process version |
| Regulatory Affairs CMC | edits | – | release data | reads | – | – | Variation to the authority |
| Tableting | manufacturing instructions | own line | IPC | reports | – | – | eBR step of the shift |
| QC lab | test method | reads | edits | reads | – | – | Test result |
| Purchasing | – | – | incoming inspection | – | edits | – | Order |
| HR | – | – | – | – | – | edits | – |
| Auditor, time-limited access | – | selection | selection | selection | selection | – | – |
| Process agent, AI coworker | manufacturing instructions | reads | IPC | – | – | – | Never |
| Deviation agent, on someone’s behalf | As much as the person who starts it. No more. | Never | |||||
Every room has keys. They come from your systems and never multiply on their own.
Whoever develops the process, files it with the authority or certifies the batch sees the whole dossier. Tableting sees the manufacturing instructions for its line, the lab the test method. If the shift lead starts the deviation agent, it sees no dossier.
An agent carries the keys of the person it works for. An AI coworker has its own, and always a person who is accountable for it. Every access is in the audit trail.
Medicines from Basel. Since 1912.
Two pharmacists found a lab for tablets and powders in Kleinbasel. They supply pharmacies along the Upper Rhine.
The first in-house substance reaches the market as a tablet. On the edge of Basel, the plant for solid dosage forms is built.
Rhenalis goes public and takes over plants in Lyon and Milan. Research in Leiden joins in 1998, Boston in 2006.
11,000 people at 15 sites in 14 countries. The Basel plant runs granulation, pelletising, six tablet presses, three coaters, capsule filling and four packaging lines with serialisation.
The payoff
| Start | Use case | Volume per month | Share | Today per year | Freed up | Value per year |
|---|---|---|---|---|---|---|
| 1 | PQR: every batch of the year in one draftQA, Quality Control | 4 × 32 h | 30% | 1,536 h | 276 h | €17,940 |
| 2 | Settle a GMP deviation with every past caseQA, Manufacturing | 25 × 4 h | 25% | 1,200 h | 180 h | €11,700 |
| 3 | Audit evidence in one placeQA, Audits & suppliers | 2 × 16 h | 30% | 384 h | 69 h | €4,485 |
| 4 | Trace batches and serial numbersQA, Supply Chain | 10 × 2 h | 40% | 240 h | 58 h | €3,770 |
| 5 | Flag process drift before scrap appearsManufacturing, Process Development | 8 × 4 h | 25% | 384 h | 58 h | €3,770 |
| Total | 3,744 h | 641 h | €41,665 |
Of 3,744 hours, we count 641: volume times time times twelve months, then only the cautious share of that, times 0.6 for partly digital processes. That is about 0.4 full-time roles. Calculated at €65 per hour: €49.50 labour cost in manufacturing according to Destatis, plus workplace, IT and overheads. For PQR and deviations: demi drafts, QA assesses and signs. Does a number not fit your company? You change every one in the configurator.
Office & Lab <=> Plant Floor
demi can work at all 14 stations. Pick a use case and see which ones it touches.
The start
| The first 90 days | Day 1 | Week 1 | Weeks 2 to 4 | Months 2 and 3 |
|---|---|---|---|---|
| Systems | ||||
| LIMS, QMSRead-only, via a small connector in their own network | Read-only, via a small connector in their own network | |||
| MES with eBR, ERPRead-only: batches, weighings, IPC values | Read-only: batches, weighings, IPC values | |||
| DMSRead-only: SOPs, reports, evidence | Read-only: SOPs, reports, evidence | |||
| Process databaseRead-only: presses, granulators, coaters | Read-only: presses, granulators, coaters | |||
| Use cases | ||||
| 1 PQRFrom week 1. QA assesses and signs | From week 1. QA assesses and signs | |||
| 2 DeviationsFrom week 1. QA classifies | From week 1. QA classifies | |||
| 3 AuditsHead of QA approves the package | Head of QA approves the package | |||
| 4 TraceabilityQA decides on the hold | QA decides on the hold | |||
| 5 Process driftAlerts go to the shift, a person decides | Alerts go to the shift, a person decides | |||
| Writing back | ||||
| Into the QMSAfter validation, with electronic signature | After validation, with electronic signature | |||
It only needs reading: LIMS and QMS from day 1, the MES from week 1. For each product, it links batch, test result, deviation and change control. Every other use case stands on that link. And a draft stays a draft: QA assesses and signs as before.
Process monitoring learns the normal state of each press from months of process data, and its alerts go into the running shift. That needs the process database and a completed validation. After the first four use cases, both are in place.
1Data
An excerpt from Rhenalis’s record, Basel plant.
Nothing gets replaced. Running different systems? demi connects to every ERP, MES and LIMS, from the big standard packages to in-house builds. At first, demi only reads. A person connects a system after seeing who will read what.
| Parameter | Target | Actual | Source |
|---|---|---|---|
| Header | |||
| Batch 26-0409 | Finished product FT-500, 30 film-coated tablets per pack | ERP | |
| Manufacturing order | HA-26-1187, 6 to 10 Nov | MES | |
| Manufacturing instructions | HV-FT500 version 9 | DMS, MES | |
| Expiry date | 10.2029, 36 months per marketing authorisation | ERP | |
| Tableting on press T3, punch set S-T3-07 | |||
| Weight | 650 mg ±5% | Ø 651 mg | MES, IPC balance |
| Breaking force | 90 to 160 N | Ø 104 N, min. 93 N | MES, hardness tester |
| Thickness | 6.2 to 6.6 mm | 6.4 mm | MES |
| Disintegration time | max. 15 min | 6 min | MES |
| Compression force | 14 to 20 kN | Ø 17.8 kN | Process database, T3 |
| Lab, sample L-26-21877 | |||
| Assay | 95.0 to 105.0% | 99.6% | LIMS, SP-FT500 Rev. 6 |
| Dissolution at 30 min | min. 80% (Q) | 91% | LIMS, Ph. Eur. 2.9.3 |
| Uniformity of dosage units | AV max. 15 | 4.2 | LIMS, Ph. Eur. 2.9.40 |
| Water content | max. 3.0% | 2.1% | LIMS |
| Packaging and release | |||
| Packaging, line V2 | 30 tablets, 3 blisters of 10 | 15,912 folding boxes | MES |
| Serial numbers | one per folding box | 15,912 reported | MES, serialisation |
| Deviation AB-26-0731, press T3Open | closed before certification | open, impact assessment under way | QMS |
| Certification | by the Qualified Person, after AB-26-0731 is closed | QMS | |
Wholesaler #4471 is waiting for 4,000 packs of batch 26-0409: FT-500 to HV-FT500 v9, pressed on T3.
Who?
#4471Wholesaler, Germany, 4,000 packs#4502Wholesaler, Austria, 2,500 packsOE-QA-OPSQA OperationsQP-02Qualified PersonERP, QMSwaiting for this batch
What kind?
FT-500Film-coated tablet 500 mg, Alu/PVdC blisterHV-FT500 v9Manufacturing instructionsWS-26-0117Active substance batchHS-26-0842Microcrystalline cellulose, new supplier since AugustERP, DMSmade to HV-FT500 v9
Where?
T3Rotary press, room 2.14C2CoaterV2Packaging line with serialisationQL-3Quarantine storeMES, ERPpressed on T3
What’s going on?
HA-26-1187Manufacturing orderL-26-21877Sample for release testingAB-26-0731Deviation at T3, batch 26-0412MES, LIMS, QMSorder, sample, deviation
Which one exactly?
Batch 26-0409
ERPFinished batch
What applies?
MA-FT500Marketing authorisation, module 3RV-4471-03Supply contract with wholesaler #4471DMS, ERPsold under RV-4471-03
What’s in writing?
SOP-QA-014Deviations and CAPACC-26-0093Change control: new cellulose supplierPQR-FT500-25PQR of the previous yearDMS, QMSdescribes this batch
What should it be?
SP-FT500 Rev. 6Assay 95.0 to 105.0%, dissolution Q 80% at 30 minHV-FT500 v9Breaking force 90 to 160 NST-FT500Stability at 25 °C and 60% RH, 36 monthsLIMS, DMSapplies to this batch
What do we make of it?
F-26-211Breaking force within target, close to the limitF-26-212Dissolution 3 points lower since the supplier change, within targetdemifinding on this batch
At the pump maker, the pump with its serial number sits in the middle; at the machine builder, the line at the customer’s site. At Rhenalis, it is the batch, packed in 15,912 folding boxes with a serial number each. The grid stays, the middle changes.
Batch 26-0409 in the ERP, “FT500-0409” in the LIMS and “260409” in the setup log are the same batch.
“MCC 102”, “cellulose, microcrystalline” and material 200417 become one excipient per Ph. Eur.
Every value shows its source, exact location and version. Unclear rows are kept too.
Manufacturing instructions HV-FT500 as they stood on 6 November: version 9.
After approval, the report lands in the QMS, with person and time in the audit trail.
3Intelligence
AI coworker, accountable: Head of QA
Works for the person who starts it
AI coworker, accountable: Head of Audits & suppliers
AI coworker, accountable: Head of QA Operations
AI coworker, accountable: Head of Process Development
A person decides on classification, CAPA and approval, as the SOPs lay down. Rhenalis validates demi like any GxP system under Annex 11 and 21 CFR Part 11. Every access and every change is in the audit trail.
Calculations run on the data from LIMS, MES and QMS, not in the language model. Whatever is written back into a GMP system, a person approves, with an electronic signature.
The roadmap
Before the certificate, the Qualified Person checks the batch file, lab values, open deviations and change controls. demi puts it all together per batch and shows only what stands out. Certifying stays with them.
After the presses, the coaters and the capsule filling machines: spray rate, inlet air temperature, fill weight. demi reports drift there too, before an IPC value reaches the limit.
From every change control, the question whether the authorisation needs a variation notification. Plus a weekly plan for six presses that knows cleaning and punch changes, and suppliers with their qualification.
Sources
Through 2026, Gartner expects organisations to abandon 60% of AI projects that lack AI-ready data.
Gartner · 2025 · on step 1, dataOpen the source (opens in a new tab)Share sensitive data in LLM apps on a least-privilege basis only, meaning just what a user or process needs.
OWASP GenAI Security Project · 2025 · on step 2, rightsOpen the source (opens in a new tab)70% of AI’s potential value sits in core functions such as sales, manufacturing and supply chain.
Boston Consulting Group · 2025 · on step 3, intelligenceOpen the source (opens in a new tab)In 20 minutes we show you demi on a case like yours: bring the data together, set the rights, let AI do the work.
Rhenalis does not exist: a made-up example company from Pharma & Biotech, not a real one. An estimate from our assumptions, not a promise. You can change every number in the configurator.